We found positive correlations of PD-1+ cTFH cells and Env-specific cTFH cells with LN-TFH cells as early as day 3 following immunizations, supporting the notion that LN and circulating TFH cellular populations are related

We found positive correlations of PD-1+ cTFH cells and Env-specific cTFH cells with LN-TFH cells as early as day 3 following immunizations, supporting the notion that LN and circulating TFH cellular populations are related. (GC) B cell affinity maturation. Circulating CXCR5+ CD4+ T (cTFH) cells have supported memory B cell activation and broadly PU 02 neutralizing antibodies in HIV controllers. We investigated the contribution of LN SIV-specific TFH and cTFH cells to Env-specific humoral immunity in female rhesus macaques following a mucosal Ad5hr-SIV recombinant priming and SIV gp120 intramuscular improving vaccine regimen and following SIV vaginal challenge. TFH and B cells were characterized by circulation cytometry. B cell help was evaluated in TFH-B cell co-cultures and by real-time PCR. Vaccination induced PU 02 Env-specific TFH and Env-specific memory (ESM) B cells in LNs. LN Env-specific TFH cells post-priming and GC ESM B cells post-boosting correlated with rectal Env-specific IgA titers, and GC B cells at the same timepoints correlated with vaginal Env-specific IgG titers. Vaccination expanded cTFH cell responses, including CD25+ Env-specific cTFH cells that correlated negatively with vaginal Env-specific IgG titers but positively with rectal Env-specific IgA titers. Although cTFH cells post-2nd boost positively correlated with viral-loads following SIV challenge, cTFH cells of SIV-infected and guarded macaques supported maturation of circulating B cells into plasma cells and IgA release in co-culture. Additionally, cTFH cells of na?ve macaques promoted upregulation of genes associated with B cell proliferation, BCR engagement, plasma cell maturation, and antibody production, highlighting the role of cTFH cells in blood B cell maturation. Vaccine-induced LN TFH and GC B cells supported anti-viral mucosal immunity while cTFH cells provided B cell help in the periphery during immunization and after SIV challenge. Induction of TFH responses in blood and secondary lymphoid organs is likely desirable for protective efficacy of HIV vaccines. (14C16). This peripheral subpopulation exhibited a similar transcriptional profile as GC TFH cells (14), and therefore was identified as circulating T follicular helper (cTFH) cells (17C19). HIV-specific cTFH cells were found to be increased in the blood of RV144 PU 02 vaccine recipients, and these cells have been associated with breadth of NAbs in HIV infected patients, suggesting a role in HIV protection (12, 17, 20, 21). Growth of HIV-specific memory cTFH cells has also been associated with development of bNAbs in HIV-infected individuals (20, 22, 23), supporting the role of cTFH cells in development of humoral responses against HIV. Growth of HIV-specific cTFH cells seen in HIV elite controllers suggested a contribution to HIV-specific IgG responses and preservation of HIV-specific memory B cell Rabbit Polyclonal to HBP1 responses in the blood circulation (24). Development of vaccine-induced HIV-specific humoral responses is usually highly dependent on selection of the HIV-specific B cell repertoire, a process that requires integral participation of HIV-specific TFH PU 02 cells (25). Induction of Env-specific TFH cell responses by immunization strategies would provide important signals for elicitation of Env-specific antibody responses. Although TFH cells have been intensively investigated during HIV and SIV contamination, less is known about TFH cell responses during HIV/SIV immunization and how these TFH responses contribute to protective PU 02 humoral immunity. In the rhesus macaque SIV/SHIV models, TFH cells have been shown to be induced by vaccination (26, 27) and suggested to play a role in protection against viral contamination (28, 29). However, vaccine-induced TFH cells have also been correlated with higher acute viral loads following SIV challenge (18). We recently reported that early induction of TFH cells in GCs of immunized rhesus macaques was important for strong GC maturation associated with viremia control following SIV contamination (30). Here, using female rhesus macaques immunized mucosally with replicating Adenovirus type 5 host range mutant (Ad5hr)-SIV recombinants followed by intramuscular gp120 protein improving (31), we expanded our investigations of TFH cells and their role in development of SIV-specific humoral responses in different mucosal and systemic tissue compartments. Although Ad5 is no longer a viable HIV vaccine candidate in human studies due to previous failures in clinical trials, several other replicating Ad-vectored methods are being explored (29, 32C34). For investigation of replicating Ad vaccines using the SIV/rhesus macaque model, we have used the Ad5hr vector because it exhibits prolonged replication in rhesus macaques cells resulting in provision of long-lasting immune responses (35C38). In this study we performed comprehensive correlation analyses between TFH subsets.

Related Post